> Investors > 

News Releases

Webcast Image Webcast
Q2 2018 Aceto Earnings Conference Call
Friday, February 02, 2018 9:00 am EST
Date Title  
Toggle Summary ACETO Corporation Schedules Second Quarter Fiscal 2018 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , Jan. 18, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
Toggle Summary ACETO Subsidiary, Rising Pharmaceuticals, Launches Efavirenz Capsules, 50mg and 200mg
PORT WASHINGTON, N.Y. , Jan. 02, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising
Printer Friendly Version
Toggle Summary ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y. , Dec. 07, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), focused on the global development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that its Board of Directors has declared a
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2018 First Quarter Results
PORT WASHINGTON, N.Y. , Nov. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2018
Printer Friendly Version
Toggle Summary ACETO Subsidiary, Rising Pharmaceuticals, Launches Sertraline Oral Solution, 20mg/ml
PORT WASHINGTON, N.Y. , Oct. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules First Quarter Fiscal 2018 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , Oct. 20, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
Toggle Summary ACETO Appoints William C. Kennally, III President and CEO
PORT WASHINGTON, N.Y. , Sept. 27, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed William
Printer Friendly Version
Toggle Summary ACETO to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
PORT WASHINGTON, N.Y. , Sept. 05, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Sal Guccione ,
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2017 Fourth Quarter and Full Year Results
PORT WASHINGTON, N.Y. , Aug. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the
Printer Friendly Version
Toggle Summary ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y. , Aug. 24, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of
Printer Friendly Version
top